GURUFOCUS.COM » STOCK LIST » Industrials » Business Services » Thelma Therapeutics (XKRX:015540) » Definitions » Cyclically Adjusted FCF per Share

Thelma Therapeutics (XKRX:015540) Cyclically Adjusted FCF per Share : ₩0.00 (As of Sep. 2022)


View and export this data going back to 1989. Start your Free Trial

What is Thelma Therapeutics Cyclically Adjusted FCF per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Thelma Therapeutics's adjusted free cash flow per share for the three months ended in Sep. 2022 was ₩-12.106. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is ₩0.00 for the trailing ten years ended in Sep. 2022.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

As of today (2024-06-07), Thelma Therapeutics's current stock price is ₩6410.00. Thelma Therapeutics's Cyclically Adjusted FCF per Share for the quarter that ended in Sep. 2022 was ₩0.00. Thelma Therapeutics's Cyclically Adjusted Price-to-FCF of today is .


Thelma Therapeutics Cyclically Adjusted FCF per Share Historical Data

The historical data trend for Thelma Therapeutics's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Thelma Therapeutics Cyclically Adjusted FCF per Share Chart

Thelma Therapeutics Annual Data
Trend Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Thelma Therapeutics Quarterly Data
Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Thelma Therapeutics's Cyclically Adjusted FCF per Share

For the Specialty Business Services subindustry, Thelma Therapeutics's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Thelma Therapeutics's Cyclically Adjusted Price-to-FCF Distribution in the Business Services Industry

For the Business Services industry and Industrials sector, Thelma Therapeutics's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Thelma Therapeutics's Cyclically Adjusted Price-to-FCF falls into.



Thelma Therapeutics Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Thelma Therapeutics's adjusted Free Cash Flow per Share data for the three months ended in Sep. 2022 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Sep. 2022 (Change)*Current CPI (Sep. 2022)
=-12.106/114.8313*114.8313
=-12.106

Current CPI (Sep. 2022) = 114.8313.

Thelma Therapeutics Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201212 1,650.094 97.168 1,950.050
201303 -104.089 97.987 -121.982
201306 -1,444.062 97.732 -1,696.717
201309 -782.170 98.479 -912.048
201312 -452.622 98.279 -528.853
201403 -751.281 99.253 -869.199
201406 -938.935 99.353 -1,085.213
201409 -326.661 99.608 -376.585
201412 0.891 99.098 1.032
201503 -79.376 99.720 -91.404
201506 -538.515 100.050 -618.075
201509 -1,446.200 100.110 -1,658.866
201512 -1,417.349 100.220 -1,623.988
201603 -3,400.450 100.560 -3,883.036
201606 -719.103 100.790 -819.283
201609 -384.154 101.460 -434.781
201612 -162.069 101.560 -183.247
201703 -115.957 102.850 -129.465
201706 -597.998 102.610 -669.222
201709 -1,029.244 103.490 -1,142.037
201712 247.202 102.990 275.624
201803 -425.491 104.100 -469.353
201806 -463.576 104.130 -511.217
201809 -77.364 105.650 -84.087
201812 -992.108 104.350 -1,091.759
201903 -483.447 104.490 -531.293
201906 522.244 104.880 571.796
201909 -510.901 105.200 -557.675
201912 -578.732 105.120 -632.197
202003 -70.282 105.540 -76.469
202006 -124.310 104.870 -136.118
202009 -174.030 106.200 -188.174
202012 -165.188 105.765 -179.347
202103 -248.099 107.357 -265.371
202106 -283.258 107.579 -302.355
202109 -15.409 108.759 -16.269
202112 -570.692 109.676 -597.515
202203 -16.863 111.806 -17.319
202206 -24.434 114.083 -24.594
202209 -12.106 114.831 -12.106

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.


Thelma Therapeutics  (XKRX:015540) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Thelma Therapeutics Cyclically Adjusted FCF per Share Related Terms

Thank you for viewing the detailed overview of Thelma Therapeutics's Cyclically Adjusted FCF per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Thelma Therapeutics (XKRX:015540) Business Description

Traded in Other Exchanges
N/A
Address
Mapo-gu, Seoul Sangam DMC Prugio City, 25, World Cup Buk-ro 54-gil, Seoul, KOR
Thelma Therapeutics, formerly Medipartner Biotechnology is a South Korean company engaged in providing hospital management support, dental material distribution, medical devices manufacturing, and development of new materials.

Thelma Therapeutics (XKRX:015540) Headlines

No Headlines